3tbiosciences logo

3T Biosciences, Inc.

3T Biosciences is a startup biotech focusing on identification and validation of novel TCRs and the development of novel, TCR based therapeutic programs, with improved therapeutic indexes.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.3tbiosciences.com
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Menlo Park, California,CA,
Menlo Park
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider”
linkedin_id=”https://www.linkedin.com/company/3tbiosciences” connections=”true” suffix=””]

3T Biosciences proprietary experimental and computational technology allows to identify novel T cell receptor targets as well as clinical toxicities to bring safe and effective therapies.

In Feb 2017, 3T Biosciences, raised $12 Mn in a seed funding round led by investors Sean Parker alongside fellow billionaire investor Peter Thiel.